Michael Sistenich
NON-EXECUTIVE DIRECTOR
Opthea
Australia
Biography
Michael Sistenich was appointed Non-executive Director of Opthea in November 2015. He has over 18 years of experience as a healthcare specialist in international investment management and investment banking. He has advised numerous global institutional investors, high net worth individuals and companies on healthcare investments in public and private markets. He is currently Head of Corporate Development at Nohla Therapeutics Inc., a Seattle based biotechnology company and his previous roles include Director of Corporate Finance at Bell Potter Securities and Director of International Equities and Head of Global Healthcare Investments at Deutsche Bank.
Research Interest
research interest on business developemnt
